<DOC>
	<DOCNO>NCT00940641</DOCNO>
	<brief_summary>The purpose study evaluate absorption , distribution , metabolism excretion AZD7325 intravenous 14C labeled oral dose</brief_summary>
	<brief_title>Assess Absorption , Distribution , Metabolism Excretion AZD7325 After Intravenous Oral Administration</brief_title>
	<detailed_description />
	<criteria>Healthy subject Day 1 Body Mass Index ( BMI ) &gt; 18 &lt; 30kg/m2 Clinically relevant disease abnormality ( past present ) opinion investigator , may either put subject risk participate study may influence result study subject 's ability participate study Use prescription medication within 14 day first dose investigational product Blood loss excess 200 mL within 30 day Day1 excess 500 mL within 90 day Day1 excess 1350 mL within 1 year Day1 donation blood product within 14 day Day 1</criteria>
	<gender>Male</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Healthy Volunteer</keyword>
</DOC>